T. Rowe Price Associates’s iShares Biotechnology ETF IBB Stock Holding History

T. Rowe Price Associates’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$381K	Hold	2,000	–	–	﹤0.01%	2750
2026 Q1	$338K	Hold	2,000	–	–	﹤0.01%	2630
2025 Q4	$338K	Hold	2,000	–	–	﹤0.01%	2588
2025 Q3	$289K	Sell	2,000 -1,614	-45%	-$220K	﹤0.01%	2620
2025 Q2	$458K	Hold	3,614	–	–	﹤0.01%	2347
2025 Q1	$463K	Hold	3,614	–	–	﹤0.01%	2277
2024 Q4	$478K	Hold	3,614	–	–	﹤0.01%	2305
2024 Q3	$527K	Hold	3,614	–	–	﹤0.01%	2225
2024 Q2	$497K	Hold	3,614	–	–	﹤0.01%	2189
2024 Q1	$496K	Hold	3,614	–	–	﹤0.01%	2214
2023 Q4	$491K	Hold	3,614	–	–	﹤0.01%	2180
2023 Q3	$442K	Hold	3,614	–	–	﹤0.01%	2169
2023 Q2	$459K	Hold	3,614	–	–	﹤0.01%	2177
2023 Q1	$467K	Hold	3,614	–	–	﹤0.01%	2140
2022 Q4	$474K	Hold	3,614	–	–	﹤0.01%	2152
2022 Q3	$423K	Hold	3,614	–	–	﹤0.01%	2212
2022 Q2	$425K	Hold	3,614	–	–	﹤0.01%	2285
2022 Q1	$471K	Hold	3,614	–	–	﹤0.01%	2368
2021 Q4	$552K	Hold	3,614	–	–	﹤0.01%	2340
2021 Q3	$584K	Hold	3,614	–	–	﹤0.01%	2306
2021 Q2	$591K	Sell	3,614 -89	-2%	-$13.7K	﹤0.01%	2311
2021 Q1	$558K	Buy	3,703 +89	+2%	+$14.1K	﹤0.01%	2318
2020 Q4	$547K	Buy	+3,614	New	+$516K	﹤0.01%	2206

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

T. Rowe Price Associates's IBB Position: Q2 2026 in Review

T. Rowe Price Associates held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,000 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

T. Rowe Price Associates first reported a position in IBB in Q4 2020 and has held it in 23 quarters since. The position peaked at $591K in Q2 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

T. Rowe Price Associates held 2,000 shares of iShares Biotechnology ETF worth $381K as of Q2 2026.
T. Rowe Price Associates left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2750 holding.
T. Rowe Price Associates first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 23 quarters since.
T. Rowe Price Associates's iShares Biotechnology ETF position peaked at $591K in Q2 2021.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.